Fig 1.
Selection of the study population.
This figure displays the participation disposition flow for the study.
Fig 2.
Prevalence of delayed viral suppression by geographic region (department) in Haiti between 2013 and 2017.
This figure shows the prevalence of delayed viral suppression among persons newly-initiated on antiretroviral therapy by the geographic department in which they received clinical care between 2013 and 2017. ‘Sud’ department in this image represents Grande Anse, Nippes, Sud, and Sud-Est departments combined.
Table 1.
Demographic and clinical characteristics of persons living with HIV in Haiti by virologic status, 2013–2017.
Table 2.
Odds Ratios (OR) and 95% Confidence Intervals (CI) of demographic and clinical characteristics associated with delayed viral suppression in Haiti, 2013–2017.